Cargando…
Co-Targeting FASN and mTOR Suppresses Uveal Melanoma Growth
SIMPLE SUMMARY: Metastatic uveal melanoma is often difficult to treat due to the lack of effective treatment options. Cancer cells rewire their metabolic features to support their energy needs for tumor growth and progression, and therefore targeting metabolic pathways may be a potential therapeutic...
Autores principales: | Han, Anna, Mukha, Dzmitry, Chua, Vivian, Purwin, Timothy J., Tiago, Manoela, Modasia, Bhavik, Baqai, Usman, Aumiller, Jenna L., Bechtel, Nelisa, Hunter, Emily, Danielson, Meggie, Terai, Mizue, Wedegaertner, Philip B., Sato, Takami, Landreville, Solange, Davies, Michael A., Kurtenbach, Stefan, Harbour, J. William, Schug, Zachary T., Aplin, Andrew E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341317/ https://www.ncbi.nlm.nih.gov/pubmed/37444561 http://dx.doi.org/10.3390/cancers15133451 |
Ejemplares similares
-
Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma
por: Terai, Mizue, et al.
Publicado: (2021) -
Development and optimization of orthotopic liver metastasis xenograft mouse models in uveal melanoma
por: Sugase, Takahito, et al.
Publicado: (2020) -
Dual Targeting of CDK4/6 and cMET in Metastatic Uveal Melanoma
por: Ohara, Masahiro, et al.
Publicado: (2021) -
Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma
por: Chua, Vivian, et al.
Publicado: (2019) -
The Role of HGF/MET Signaling in Metastatic Uveal Melanoma
por: Tanaka, Ryota, et al.
Publicado: (2021)